New drug combo aims to boost stem cell harvest for myeloma patients
Disease control
Completed
This phase 2 study tests whether a new drug called GPC-100, combined with propranolol and with or without G-CSF, can effectively mobilize stem cells in people with multiple myeloma who are preparing for an autologous stem cell transplant. The goal is to see if enough stem cells c…
Phase: PHASE2 • Sponsor: GPCR Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC